Timmy Lee, MD, MSPH, is Associate Professor of Medicine in the Division of Nephrology and Staff Nephrologist at the Birmingham Veterans Affairs Medical Center. He is the Associate Director of Interventional Nephrology, Director of Hemodialysis at the Birmingham Veterans Affairs Medical Center, and Associate Fellowship Director of UAB Nephrology Fellowship Program. He also currently serves as a Councilor for the American Society of Diagnostic and Interventional Nephrology.
Dr. Wadley Bradley is a licensed medical/clinical psychologist and Associate Professor of Medicine within the Division of Gerontology, Geriatrics, and Palliative Care. She is also Director of the Dementia Care Research Program of the Comprehensive Center for Healthy Aging
Dr. Di Stasi is Assistant Professor of Medicine in the Bone Marrow Transplantation and Cell Therapy Program Unit, where he performs both clinical and translational research activities. His primary research focus involves the pre-clinical validation of adoptive T cell immunotherapy strategies for hematologic malignancies.
Dr. Kirk M. Habegger is Assistant Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism. He obtained his Ph.D. in Biochemistry and Molecular Biology from Indiana University School of Medicine in 2006. He conducted his postdoctoral training under the mentorship of Drs. Matthias Tschoep and Randy Seeley at the Metabolic Diseases Institute of the University of Cincinnati from 2009 to 2013. He was promoted to the faculty at UC in the Department of Medicine, before leaving to start his group at UAB.
Dr. Hage is Associate Professor of Medicine in the Division of Cardiovascular Disease, Director of Nuclear Cardiology at UAB, and Director of the Cardiac Care Unit at the BVAMC. He is also a member of the Vascular Biology and Hypertension Program.
In 2014, Dr. Hage and collaborators demonstrated that the effects of estrogen therapy on vascular inflammation are age dependent. In 2002, the Women’s Health Initiative (WHI) reported increased cardiovascular events in women treated with menopausal hormones compared to placebo. These results were in contrast to the well-established anti-inflammatory and vasoprotective effects